Medizone Welcomes Boyd Evans as its Chief Financial Officer

boyd

At a recent Board of Directors meeting, Mr. Boyd Evans was welcomed as our Company’s new Chief Financial Officer. The timing of Mr. Evans’ appointment coincides with the anticipation of increased production requirements and expansion into new markets as regulatory approval efforts move forward not only in the U.S. but Chile, Peru, Columbia and Brazil. In the U.S., we have experienced increasing levels of interest from both the private and government hospital sectors since announcing our Generation III AsepticSure System. The Company is currently more optimistic about the prospects for commercial success than at any other time in its recent history, making Mr. Evans’ experience both timely and appropriate as he takes up his new role.

Mr. Evans has 15 years of experience as a highly skilled finance leader. His experience spans expertise in financial accounting and systems management in rapidly growing and complex environments. He brings a strong background in managing operations and finance together with system analysis and implementations. Mr. Evans also has an understanding of business cycles and financial operations from purchasing through manufacturing and sales, as well as strategic planning, budgeting, forecasting, contract proposals, government contract regulations, and reporting.

Mr. Evans most recently served as Vice President of Finance and Business Systems for BioFire Defense, a company in the medical diagnostics arena. He directed the operational functions of Finance and the IT teams during an acquisition by bioMerieux, SA, a company operating in over 150 countries with annual revenues of €1.965 billion in 2015.

Mr. Evans’ experience is clearly a fit Medizone is pleased to bring onto our team. Boyd is a Certified Public Accountant, with a BA in Information Systems, a BS in Accounting and an MBA from the University of Utah.

Welcome aboard Boyd!

Edwin G. Marshall
Chairman of the Board
Chief Executive Officer

 

Premier Kathleen Wynne of Ontario, Canada visits Medizone’s Laboratories

eeeee
Medizone International was honored and pleased this past week to have Premier Kathleen Wynne and her staff, visit our Innovation Park laboratories on Thursday, March 31st.

Dr. Michael Shannon offered a presentation on our AsepticSure® Hospital Disinfection System and its un-paralleled achievement of demonstrating greater than 6-log (>99.9999%) kill of infective pathogens both in-laboratory and in-hospital. A senior AsepticSure development partner located at Innovation Park, Matthew Deir of Dragonfly IT Inc., also participated in the presentation. Matthew explained the synergy of companies working together at Innovation Park in progressing commercial development.

Premier Wynne’s Chief of Staff left the meeting with a package of information regarding the unprecedented scientific achievement of AsepticSure in demonstrating outstanding long-term reductions in HAI, as well as the astonishing financial savings demonstrated as obtainable to the health care system following AsepticSure’s adoption. The financial savings are based on the results of our work at Belleville General Hospital with MRSA and Trenton Memorial Hospital with C.difficile.

Following the presentation, the first question the Premier asked was, “Why is this not in every hospital in Ontario?”

 

South Africa Interest in AsepticSure

The week before Premier Wynne’s visit, On March 23, 2016, Medizone’s Laboratory Manager, Kelly Brown, had the privilege of meeting with South African Consulate General, Nyameko Goso as well as the Consulate Political, Reginold A Ncamane, who were on a tour of Kingston’s Innovation Park to meet with innovators who they could possibly build partnerships with.

Kelly was given the opportunity to represent Medizone and the AsepticSure system in presenting an outline of what the system is capable of achieving. She reported that both gentlemen were very receptive. Further communication with Reginold A. Ncamane has since occurred. We are now in contact with the South African Trade Commission who are working to arrange Medizone’s possible presence at the South African Health Conference, June 8-10 in Johannesburg.

The marketing of AsepticSure in South Africa has also been discussed.

Medizone International, Inc. (OTCQB: MZEI)

4000 Bridgeway, Suite 401
Sausalito, CA 94965

Telephone: 415-331-0303

Email: operations@medizoneint.com

Media and Investor Relations:

John Pentony

Medizone International, Inc.

Telephone: (415) 331-0202

Email: j.pentony@medizoneint.com

Social Media


Twitter:


https://twitter.com/asepticsure

CONTACT:

Medizone International, Inc. (OTCQB: MZEI)
4000 Bridgeway, Suite 401
Sausalito, CA 94965

Telephone: 415-331-0303

Email: operations@medizoneint.com

INVESTOR & MEDIA RELATIONS:

John Pentony
Medizone International, Inc.

Telephone: (415) 331-0202E:

Email: j.pentony@medizoneint.com

SOCIAL MEDIA:

Medizone International on Twitter:

https://twitter.com/asepticsure